<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[10, 12] elderly patients<br>[51, 56] hypertension in older patients.<br>[67, 125] British Medical Research Council (MRC) trial of treatment in older adults, the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) and the Systolic Hypertension in the Elderly Program (SHEP)--have conclusively established the benefits of treating older patients (> 60 years) with both diastolic and isolated systolic hypertension.<br>[202, 207] older individuals with hypertension.<br></td>
<td width=33%>
[2, 4] stroke.<br>[10, 12] elderly patients<br>[51, 56] hypertension in older patients.<br>[67, 125] British Medical Research Council (MRC) trial of treatment in older adults, the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) and the Systolic Hypertension in the Elderly Program (SHEP)--have conclusively established the benefits of treating older patients (> 60 years) with both diastolic and isolated systolic hypertension.<br>[202, 207] older individuals with hypertension.<br></td>
<td width=33%>
[2, 4] stroke.<br>[10, 12] elderly patients<br>[51, 56] hypertension in older patients.<br>[56, 110] Since 1991, the results of 3 major trials--the British Medical Research Council (MRC) trial of treatment in older adults, the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) and the Systolic Hypertension in the Elderly Program (SHEP)--have conclusively established the benefits of treating<br>[200, 207] treatment of older individuals with hypertension.<br></td>
</tr>
